BRK-B · CIK 1067983 · Annual (10-K) · Last 8 years
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $302.0B | $276.2B | $245.6B | $254.6B | $247.8B | $239.9B | $215.1B | $210.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-22.8B | $89.9B | $42.5B | $81.4B | $4.0B | $44.9B | $24.1B | $24.1B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $948.5B | $959.4B | $873.7B | $817.7B | $707.8B | $702.1B | $620.9B | $552.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $60.0B |
| Total Liabilities | $499.2B | $466.8B | — | — | $389.2B | $355.3B | $350.1B | $335.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $561.3B | $436.7B | $506.2B | $443.2B | $424.8B | $348.7B | $348.3B | $282.1B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $37.4B | $39.4B | $39.8B | $38.7B | $37.4B | $45.7B | $32.6B | $31.5B |
| Investing Cash Flow | $-87.6B | $29.4B | $-37.8B | $-5.6B | $-32.8B | $-41.0B | $-84.2B | $-28.0B |
| Capital Expenditures | $15.5B | $13.3B | $13.0B | $16.0B | $14.5B | $11.7B | $13.0B | $16.1B |
| Financing Cash Flow | $-1.7B | $-28.5B | $-18.3B | $0.7B | $-5.8B | $-1.4B | $12.8B | $3.8B |